Table 5.
Bivariate and multivariate logistic regression analysis of factors associated with early, late and long-term readmissions
| Early readmission Odds Ratio (95% CI) |
Late readmission Odds Ratio (95% CI) |
Long-term readmission Odds Ratio (95% CI) |
||||
|---|---|---|---|---|---|---|
| Unadjusted | Adjusted1 | Unadjusted | Adjusted1 | Unadjusted | Adjusted1 | |
| Detection mode | ||||||
| Screen-detected | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| Interval cancer | 1.14 (0.70–1.86) | 0.73 (0.32–1.66) | 0.86 (0.53–1.40) | 0.60 (0.23–1.53) | 1.54 (0.94–2.53) | 0.65 (0.22–1.88) |
| Tumor-node-metastasis stage | ||||||
| In situ | 0.73 (0.30–1.78) | 1.44 (0.14–15.15) | 0.94 (0.42–2.07) | 2.55 (0.24–27.53) | 1.25 (0.45–3.46) | 5.21 (0.31–88.88) |
| Stage I | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| Stage II | 0.97 (0.57–1.65) | 0.65 (0.26–1.61) | 0.96 (0.57–1.61) | 1.93 (0.68–5.46) | 2.29 (1.25–4.22) | 0.93 (0.30–2.92) |
| Stage III/IV | 0.61 (0.26–1.39) | 0.27 (0.06–1.30) | 0.93 (0.46–1.86) | 2.71 (0.55–13.42) | 3.31 (1.66–6.62) | 1.64 (0.33–8.10) |
| Surgical treatment | ||||||
| Conservative2 surgery without lymphadenectomy | 1.65 (0.96–2.84) | 2.91 (1.13–7.52) | 1.09 (0.66–1.78) | 1.26 (0.45–3.53) | 0.45 (0.22–0.92) | 0.46 (0.11–1.87) |
| Conservative2 surgery with lymphadenectomy | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| Radical3 surgery with or without lymphadenectomy | 1.54 (0.82–2.89) | 2.54 (0.84–7.71) | 0.76 (0.40–1.45) | 0.46 (0.12–1.76) | 2.04 (1.17–3.55) | 1.57 (0.46–5.30) |
| Surgical complications4 | ||||||
| No | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| Yes | 1.91 (1.09–3.34) | 3.62 (1.27–10.29) | 1.13 (0.62–2.05) | 1.23 (0.36–4.16) | 1.33 (0.71–2.49) | 0.59 (0.18–1.97) |
| Medical complications5 | ||||||
| No | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| Yes | 2.55 (1.50–4.32) | 2.69 (0.84–8.60) | 3.28 (2.02–5.32) | 8.72 (2.83–26.86) | 3.76 (2.24–6.31) | 4.79 (1.41–16.31) |
1 Model adjusted by age, Charlson Index, detection mode, tumor-node metastasis stage, focality, tumor grade, tumor phenotype, surgical and adjuvant treatment, general complications, surgical and medical complications, and screening program
2 Included: quadrantectomy, tumorectomy, and segmentectomy
3 Included: simple mastectomy, radical mastectomy, and modified radical mastectomy
4 Included: lymphedema, adhesions, skin infection, and soft tissue necrosis
5 Included: treatment toxicity, endometrial alterations, hypothyroidism, mycosis, vascular insufficiency, asthenia, palpitations, mastitis, and depression